Medical Devices Startups

10XBeta Venture Studio operates as a venture studio that invests in and supports healthcare startups developing connected medical devices, offering co-investment opportunities backed by expertise in product development, commercialization, and manufacturing.

0 investors

Vantis Vascular develops vascular intervention technology, including the CrossFast integrated vascular delivery system with an auto-locking inner monorail microcatheter and outer delivery catheter for complex PCI procedures. Founded by physicians, the company is also developing next-generation intravascular lithotripsy (IVL) and peripheral below-the-knee (BTK) solutions for vascular interventionalists.</parameter> <parameter name="founders">[{"full_name": "Jason Turner", "title": "Chief Executive Officer"}, {"full_name": "Tim Fischell", "title": "Chief Medical Officer"}, {"full_name": "Frank Saltiel", "title": "Chief Clinical Officer"}, {"full_name": "Gary McCord", "title": "Chief Commercial Officer"}, {"full_name": "Mike Mirizzi", "title": "Chief Technology Officer"}, {"full_name": "Marc Monahan", "title": "Chief Financial Officer"}]</parameter> <parameter name="hq_city">San Jose

0 investors

Vasc-Alert provides surveillance reports and monitoring technology to help clinicians manage vascular access in dialysis patients. It serves nephrology and dialysis providers, with clinical support offered across North America and the UK.

0 investors

Vascudyne develops allograft tissue engineered from biological materials for regenerative medical applications, including heart valve therapies. The company advances non-immunogenic tissue solutions for clinical use.

0 investors

Vascular Perfusion Solutions develops the VP.S ENCORE, a portable cardiac perfusion system using a blood-free perfusate to extend donor heart viability up to 8 hours for transplant recovery teams. The investigational medical device is in preclinical evaluation under FDA Breakthrough Device Designation.

0 investors

Vascular Pharmaceuticals develops VPI-2960B, a therapeutic candidate in clinical development for diabetic nephropathy treatment. The company focuses on advancing this potential breakthrough therapy through Phase 2 trials.

0 investors

Vector Biomed develops lentiviral vectors for cell and gene therapy, focusing on affordable, scalable vector solutions with transparent pricing and no hidden royalties. It positions itself as a manufacturing and development partner for researchers and therapeutic developers.

0 investors

Vega Surgical develops neurosurgical devices, including the XCAPE cranial port and XPD access system, for cranial access and controlled fluid evacuation in treating chronic subdural hematomas (CSDH). The Colorado-based company's products are designed for neurosurgeons and hospitals to improve patient outcomes and procedure efficiency.

0 investors

Ventis Medical develops portable emergency ventilators for emergency medical teams and EMS/transport settings as an alternative to manual bag valve devices. Its FDA-cleared HeroVent offers invasive and non-invasive ventilation modes with monitoring of volume, pressure, FiO2, and EtCO2.

0 investors

VentriFlo develops the VentriFlo True Pulse Pump, a blood pumping technology based on a suspended magnet linear motor coupled to a flexible diaphragm for cardiac surgery and perfusion applications. The company builds medical devices for hospitals and cardiac surgery programs.

0 investors

Verasonics builds research ultrasound platforms (including the Vantage NXT and Vantage Research systems) that let users acquire, store, process, and analyze ultrasound data with programmable SDKs and real-time raw channel data access. It serves researchers and product developers across fields such as biomedical, material sciences, earth sciences, and biometrics, and its systems are for laboratory research/development rather than approved clinical use.

0 investors

Veris Health offers the Veris Cancer Care Platform, which connects cancer patients and clinicians through symptom reporting, physiologic data from VerisBox connected devices, secure messaging, and video calls. It provides a clinician portal with EHR integration, quality-of-life assessments, and a patient app designed for value-based oncology care aligned with the Enhancing Oncology Model.

0 investors

Verismo is a biopharmaceutical company founded by the inventors of Kymriah, the first FDA-approved CAR T cell therapy, developing next-generation CAR T therapies using KIR receptor technology to address limitations in first-generation approaches.

0 investors

Verndari develops the VaxiPatch, a single-dose vaccination kit that uses intradermal microarray technology for vaccine delivery. The company focuses on vaccine delivery methods designed to be pain-free and thermostable, with pre-clinical studies indicating higher efficacy than traditional delivery.

0 investors

Versah manufactures specialized dental implant surgical instruments and implements Osseodensification, a bone preparation technique for dental implant placement. The company serves implantologists and dental surgeons worldwide.

0 investors

Verthermia develops HEATT (Hyperthermic Extracorporeal Applied Tumor Therapy), a whole-body hyperthermia treatment that heats a patient's blood in an external circuit to raise body temperature and target cancer cells, combined with dialysis to rebalance body chemistry. The therapy is used to treat cancers and other diseases and is administered in a hospital operating room setting.

0 investors

Vesica Health develops AssureMDx, a noninvasive urine-based genomic test that analyzes DNA methylation and somatic mutation biomarkers to assess bladder cancer risk in patients presenting with hematuria. The test helps primary care physicians and urologists triage patients for referral, avoid unnecessary invasive procedures, and support early detection of bladder cancer.

0 investors

Vesiflo manufactures medical devices for urinary retention treatment, specifically targeting women with permanent conditions. The company's primary product, the inFlow Voiding Prosthesis, is designed as a safer alternative to existing bladder drainage solutions.

0 investors

Vestibular First sells equipment and education for vestibular clinicians, including infrared video goggles, vestibular apparatus, disposable cushions, and online and in-person training courses. It also produces educational content such as a monthly journal club covering vestibular research and clinical topics.

0 investors

Vicora develops a thrombectomy catheter with an integrated vibrating distal tip for removing blood clots such as those from deep vein thrombosis and pulmonary embolism. The medical device company is in pre-clinical testing and targets clinicians treating venous thromboembolism.

0 investors

VioVision is a remote training platform that enables healthcare professionals to conduct real-time instruction and mentoring sessions with physicians and surgical residents. The platform supports live annotation capabilities and is designed to reduce training time and logistical costs while improving confidence in clinical procedures.

0 investors

ViQi develops AI and imaging solutions to accelerate bioassay development for the bioprocessing industry. The company combines expertise in computer vision, machine learning, and bioprocessing to address challenges in life sciences research and manufacturing.

0 investors

VirTech Bio develops OxyBridge, a human-derived hemoglobin-based oxygen carrier (HBOC) intended as a blood substitute for time-critical trauma patients in hemorrhagic shock and for pre-transplant donor organ perfusion. The product is aimed at military and civilian trauma care and organ transplantation, using an ultra-polymer design to deliver oxygen and maintain blood pressure without refrigeration.

0 investors

Viseon Inc. develops single-use 4K imaging technology to improve intraoperative visualization for open and minimally invasive surgery, aimed at surgeons, hospitals, and surgery centers. The company operates in the medical device and surgical imaging space.

0 investors